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CASE REPORT

Corneoscleral Laceration and Ocular Burns Caused by
Electronic Cigarette Explosions
Grace L. Paley, MD, PhD,* Elizabeth Echalier, MD,† Thomas W. Eck, MD,* Augustine R. Hong, MD,*
Asim V. Farooq, MD,* Darren G. Gregory, MD,† and Anthony J. Lubniewski, MD*

Purpose: To report cases of acute globe rupture and bilateral
corneal burns from electronic cigarette (EC) explosions.

Methods: Case series.
Results: We describe a series of patients with corneal injury caused
by EC explosions. Both patients suffered bilateral corneal burns and
decreased visual acuity, and one patient sustained a unilateral
corneoscleral laceration with prolapsed iris tissue and hyphema. A
review of the scientiﬁc literature revealed no prior reported cases of
ocular injury secondary to EC explosions; however, multiple media
and government agency articles describe ﬁres and explosions
involving ECs, including at least 4 with ocular injuries.
Conclusions: Given these cases and the number of recent media
reports, ECs pose a signiﬁcant public health risk. Users should be
warned regarding the possibility of severe injury, including sightthreatening ocular injuries ranging from corneal burns to full-thickness
corneoscleral laceration.
Key Words: open-globe injury, ocular trauma, electronic cigarette,
vaping, explosion

includes the prohibition of sale to minors and a requirement that
ECs carry a warning regarding nicotine content. Notably, the
proposal does not include a warning regarding facial, oral, or
sight-threatening ocular injuries. Among the safety concerns
surrounding ECs, ﬁres and explosions have been reported in
various media outlets; in most of these cases, the presumed
mechanism is battery malfunction.
Here, we describe 2 cases of patients who suffered
multiple injuries from EC explosions. The ﬁrst patient’s ocular
injuries included a penetrating corneoscleral laceration with iris
prolapse, hyphema, an additional partial-thickness corneal
laceration, and bilateral thermal and/or chemical corneal burns.
The second patient also suffered bilateral corneal burns. To our
knowledge, these are the ﬁrst cases of ocular injury from ECs
to be reported in the scientiﬁc literature.

MATERIALS AND METHODS
The charts of 2 patients presenting with ocular injuries
from EC explosions were reviewed in accordance with the
Institutional Review Board and the Declaration of Helsinki.

(Cornea 2016;35:1015–1018)

Case 1

E

lectronic cigarette (EC) usage is on the rise in the United
States since being introduced to the market in 2006. An
estimated 3.7% of Americans are regular users based on recent
data from the Centers for Disease Control and Prevention.1 ECs
are battery-powered devices that vaporize a chemical mixture
called “e-liquid” to simulate cigarette smoking. The Food and
Drug Administration (FDA) does not currently regulate ECs,
although new regulations have been proposed.2 The proposal
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A 45-year-old man presented to the emergency department at Washington University after an EC exploded in his
mouth. On external examination, the patient was found to
have ﬁrst-degree burns to his right hand and bilateral
periocular and facial skin, and loss of 2 upper central incisors.
The patient’s facial skin and tear lakes were dusted with
numerous black particulate foreign bodies. His best-corrected
near visual acuity was 20/400 pinholing to (PH) 20/100 (J10
equivalent) in the right eye and 20/30 PH 20/20 (J1+
equivalent) in the left eye. Intraocular pressure measurement
was deferred in the right eye because of open-globe injury
and was normal in the left eye. Slit-lamp examination with
ﬂuorescein stain revealed bilateral complete corneal epithelial
defects, diffuse subconjunctival hemorrhages, and mild eyelid
edema with singeing of his eyelashes. In the right eye, he had
a 6-mm superior corneal laceration extending an additional
2 mm onto adjacent sclera with protruding iris tissue, and
a 2-mm inferior partial-thickness corneal laceration. Seidel
testing was briskly positive in the right eye, which also had
a 1-mm hyphema. The remainder of the examination revealed
trace nuclear sclerosis and a normal dilated fundoscopic
examination in both eyes. Bilateral pH testing of the ocular
surface was normal in all quadrants.
www.corneajrnl.com |
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An otolaryngology consult was obtained for his facial
and oral injuries; no acute surgical intervention was recommended. A computed tomography (CT) scan was negative for
radio-opaque intraocular or orbital foreign bodies. The patient
underwent an emergent repair of his open globe with partial
iridectomy and repositing of the remaining prolapsed iris.
Anterior chamber washout was not performed because of
intraoperative concerns regarding wound integrity. He
received moxiﬂoxacin 400 mg intravenously and a tetanus
booster. His left corneal burn was treated with a combined
neomycin (3500 I.U./g), polymixin B (6000 I.U./g), and
dexamethasone 0.1% ointment every 2 hours.
The next day, the patient’s uncorrected distance visual
acuity was 20/500 PH 20/200 in the right eye and 20/200 PH
20/100 in the left eye with normal intraocular pressures
bilaterally. In the right eye, the repaired corneoscleral laceration
was Seidel-negative and the anterior chamber had a persistent
1-mm hyphema. Diffuse mild-to-moderate corneal edema was
present bilaterally with near-complete epithelial defects and no
limbal ischemia (Figs. 1, 2). He was administered levoﬂoxacin
500 mg orally daily and combined steroid–antibiotic ointment
every 2 hours in both eyes. At subsequent postoperative visits,
his uncorrected distance vision continued to improve, eventually attaining 20/100 PH 20/40-2 in the right eye and 20/70 PH
20/25 in the left eye by the 2 months follow-up. The right
hyphema resolved within the ﬁrst week, and the bilateral
corneal epithelial defects slowly healed over the ﬁrst month.
His corneal sutures were removed after 2 months. He will
eventually undergo a rigid gas-permeable contact lens trial in
the right eye. This incident was reported to the Consumer
Product Safety Commission and the FDA.
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FIGURE 2. Case 1, extensive epithelial defect in left eye with
fluorescein stain and diffuse conjunctival injection at 1 day
after injury.

A 16-year-old male presented to the emergency department at the University of Colorado Hospital with severe
bilateral eye pain and diminished vision after his vapor pen

exploded at the chest level. He sustained burns to his face,
neck, and hands. His uncorrected visual acuity at near was
20/20 (J1+ equivalent) in the right eye and count ﬁngers at 1
foot with no improvement on pinhole in the left eye without
an afferent pupillary defect. Intraocular pressures were normal
in both eyes. His eyelids were mildly edematous and his
lashes were singed and thickly matted with black particulate
material (Fig. 3). Both conjunctivae were injected and littered
with black particles but exhibited minimal ﬂuorescein staining. The right cornea had a superotemporal epithelial burn
sparing the central visual axis, with 1 mm of limbal blanching
temporally. The left cornea had a greater than 90% surface
burn with irregular, blackened epithelium diffusely except
a small amount of sparing under the lower lid margin. The
remainder of the examination including the posterior segment

FIGURE 1. Case 1, corneoscleral laceration of the right eye
1 day after repair (Seidel-negative), epithelial defect with
fluorescein staining, persistent hyphema, and subconjunctival
hemorrhage.

FIGURE 3. Case 2, right eye at presentation with superotemporal corneal burn sparing visual axis. Note the thick,
matted black material along the lash line and partially coating
the ocular surface.
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was normal in both eyes. Bedside pH testing of the ocular
surface was normal.
The patient was admitted to the burn intensive care unit
for his face and neck injuries and for pain control. CT scan
was negative for radio-opaque intraocular or orbital foreign
bodies. Gentle debridement of the charred corneal epithelium
was performed at the bedside with copious irrigation. There
were small areas of blackened epithelium at the limbus
bilaterally that did not clear with debridement (Fig. 4). The
patient complained of a severe burning sensation with
erythromycin ointment alone, so he was placed on topical
moxiﬂoxacin 0.5% 4 times daily with soft bandage contact
lenses (BCLs) for pain relief.
The next day, the patient’s uncorrected near visual
acuity was 20/20 (J1+ equivalent) in the right eye and 20/40
(J3 equivalent) in the left eye. Mild corneal edema was
present bilaterally with trace haze, diffuse epithelial defects,
and resolution of limbal blanching. He was discharged from
the hospital with BCLs and orders for topical moxiﬂoxacin
0.5% 4 times daily and cyclopentolate 1.0% twice daily. On
day 3, his uncorrected distance vision was 20/70 PH 20/50 in
the right eye and 20/80 PH 20/60 in the left eye with normal
intraocular pressures. Although the corneal epithelial defects
had reduced in size, he had several new punctate foreign
bodies embedded superﬁcially in the cornea and conjunctiva
beneath the BCLs bilaterally. These foreign bodies were
thought to have migrated underneath the BCLs because of the
placement of the BCLs after debridement. The foreign bodies
were removed at the slit lamp and the BCLs replaced. Over
the next 2 weeks, his uncorrected distance vision progressed
to 20/20 in both eyes. The moxiﬂoxacin drops were stopped,
and topical prednisolone 1.0% was initiated. He had scattered
anterior stromal scars that faded greatly during his course. He
continued to have mild photophobia, but his pain was greatly
improved and he no longer required the BCLs.

FIGURE 4. Case 2, right eye after bedside debridement. Note
the areas of burned corneal and conjunctival epithelium with
embedded black material that did not clear with gentle
debridement, and the temporal limbal blanching.
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.
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DISCUSSION
ECs pose a number of health safety risks beyond
nicotine content and gateway drug concerns. Explosion of
ECs because of battery failure can cause serious injury to
users, including mechanical injury and thermal and/or
chemical burns. ECs may contain various materials, including
metals, plastics, rubber, and ceramics, in addition to the
battery and e-liquids ranging from nicotine to cannabis oil.3,4
It is difﬁcult to ascertain which materials may have caused
projectile damage to our patients resulting in corneal
lacerations and dental trauma, and toxic and/or caustic burns
of their ocular, mucosal, and skin surfaces. Both our patients
had black particulate foreign bodies coating or even embedded into their ocular surfaces. Their ocular injuries from
ﬂying debris may have been prevented or minimized by
protective eyewear, in keeping with the recommendations for
high-risk activities like metalworking or setting off ﬁreworks.
ECs are generally powered by lithium-ion batteries, which
contain ﬂammable and combustible liquids. ECs vary widely in
design and often include end-user–modiﬁable parts. Defective
or incorrectly matched electric currents can lead to thermal
runaway, an uncontrolled positive feedback of increased temperature that can end in combustion.3,5 By avoiding the use of
incorrectly matched chargers and ECs that can produce thermal
runaway, some of the EC explosion–related injuries reported in
the media may have been averted.5 In addition to the possibility
of direct injury to person and bystanders, there is a serious risk of
indirect injury and property damage through ignition of nearby
combustible materials. The media have reported a number of EC
explosions where individuals suffered burns, lost teeth and/or
palate trauma, neck fractures, and battery acid exposure to the
face, mouth, and eyes6,7; moreover, one user died when his
charging EC exploded and ignited adjacent oxygen equipment.8
At least 4 ocular injuries from EC explosions have been reported
by the media, the U.S. Fire Association, or MedWatch, the
FDA’s voluntary reporting site.6,7 Unfortunately, the descriptions
provided in these reports do not provide details on the scope and
severity of those injuries.
At the time of this writing, there are no regulations or
laws regarding the safety of electronics or batteries in ECs in
any country with the exception of Croatia.9 In 2014, the FDA
proposed regulating ECs like other tobacco products; however,
this proposal does not mention the risk of ﬁre, explosion, or
injury from explosion.2 Unlike most consumer products, ECs
are not required to undergo independent product safety testing;
hence, products may reach end-users without rigorous demonstration of safety features to prevent device overheating,
thermal runaway, and battery failure including ﬁre and
explosions. There is a lack of product labeling to warn users
of the potential of serious harm including mutilation and loss of
vision. In fact, many EC products are missing ingredient labels,
warnings besides nicotine content, and sometimes even
instructions for use.5 Protective eyewear and even mouthguards
may be advisable during EC use, although strict compliance is
unlikely. Although the number of serious adverse events is
small compared with the number of EC users worldwide, the
consequences may be devastating to those involved in an ECrelated blast. Because the FDA collects only voluntary reports,2
www.corneajrnl.com |
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adverse events may be underreported. Further study is
warranted to investigate the explosion hazard presented by
these devices.
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